Clinically, studies have found that higher levels of AKR1B10 expression are associated with HBV, HCV, and liver cirrhosis, which may suggest that the expression may be stimulated by the presence of such pre-HCC conditions, with a potential role in early hepatocarcinogenesis [24,26,27]. This evidence concerns the gene AKR1B10 and hepatocellular carcinoma.